Stereochemical Challenges in Developing a Commercial Synthesis of Ertugliflozin, an SGLT2 Inhibitor for the Treatment of Diabetes

Date: 
Friday, March 24, 2017 3:30 pm
Location: 
103 Schlundt Hall
Event Type: 
Speaker: 
Dr. John Ragan
Affiliation: 
Pfizer
Host: 
Harmata